1. Home
  2. WBX vs VNRX Comparison

WBX vs VNRX Comparison

Compare WBX & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WBX
  • VNRX
  • Stock Information
  • Founded
  • WBX 2015
  • VNRX N/A
  • Country
  • WBX Spain
  • VNRX United States
  • Employees
  • WBX N/A
  • VNRX N/A
  • Industry
  • WBX Industrial Specialties
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • WBX Consumer Discretionary
  • VNRX Health Care
  • Exchange
  • WBX Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • WBX 66.9M
  • VNRX 64.8M
  • IPO Year
  • WBX N/A
  • VNRX N/A
  • Fundamental
  • Price
  • WBX $4.03
  • VNRX $0.64
  • Analyst Decision
  • WBX Buy
  • VNRX Strong Buy
  • Analyst Count
  • WBX 4
  • VNRX 4
  • Target Price
  • WBX $10.50
  • VNRX $3.50
  • AVG Volume (30 Days)
  • WBX 18.3K
  • VNRX 242.2K
  • Earning Date
  • WBX 11-05-2025
  • VNRX 08-14-2025
  • Dividend Yield
  • WBX N/A
  • VNRX N/A
  • EPS Growth
  • WBX N/A
  • VNRX N/A
  • EPS
  • WBX N/A
  • VNRX N/A
  • Revenue
  • WBX $173,788,608.00
  • VNRX $1,319,252.00
  • Revenue This Year
  • WBX N/A
  • VNRX $274.46
  • Revenue Next Year
  • WBX $46.25
  • VNRX $212.60
  • P/E Ratio
  • WBX N/A
  • VNRX N/A
  • Revenue Growth
  • WBX N/A
  • VNRX 35.10
  • 52 Week Low
  • WBX $3.69
  • VNRX $0.40
  • 52 Week High
  • WBX $28.00
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • WBX 44.24
  • VNRX 47.17
  • Support Level
  • WBX $3.85
  • VNRX $0.57
  • Resistance Level
  • WBX $4.23
  • VNRX $0.73
  • Average True Range (ATR)
  • WBX 0.20
  • VNRX 0.05
  • MACD
  • WBX -0.01
  • VNRX -0.00
  • Stochastic Oscillator
  • WBX 38.29
  • VNRX 42.19

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: